Regeneron Pharmaceuticals, Inc (NASDAQ:REGN) currently has a daily average trading volume of 1.28M but it saw 1869276 shares traded in last market. With a market cap of 52.36B USD, the company’s current market price of $484.93 came falling about -0.60 while comparing to the previous closing price of $487.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $1211.20 and as low as $481.58. In the recent trading on the day, stock has struck highest price mark of $482.99 while lowest mark touched by it was $499.9.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Wells Fargo which downgraded the stock as “Equal Weight” in its note to investors issued on May 30, 2025, recommending a price target of $580 for it. RBC Capital Mkts downgraded its recommendation for the stock as a “Sector Perform” from “Outperform” on May 30, 2025 while assigning a price target of $662. Citigroup issued its recommendations for the stock as it upgraded the price target for the stock is $700.
Over the week, REGN’s stock price is moving -18.07% down while it is -19.66% when we observe its performance for the past one month. Year-to-date it is -31.92% down and over the past year, the stock is showing a downside performance of -50.53%.
Currently, Regeneron Pharmaceuticals, Inc’s total number of outstanding shares is 106.40M with 1.90% of that held by the insiders while 92.09% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 14.02% and return on equity (ROE) at 15.96%. It has a price to earnings ratio (P/E ratio) of 12.34 while having a 12.23 of forward P/E ratio. Stock’s beta reads 0.31. Stock has a price to book (P/B) ratio of 1.79 while price to sale or P/S ratio amounts to 3.72. Its return on asset (ROA) is 12.51% on average.
